-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Champions Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Champions Oncology, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was $1.33M.
- Champions Oncology, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$3.48M, a 53.8% increase year-over-year.
- Champions Oncology, Inc. annual Operating Income (Loss) for 2023 was -$7.36M, a 40% decline from 2022.
- Champions Oncology, Inc. annual Operating Income (Loss) for 2022 was -$5.26M, a 966% decline from 2021.
- Champions Oncology, Inc. annual Operating Income (Loss) for 2021 was $607K, a 65.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)